JP2007523056A5 - - Google Patents

Download PDF

Info

Publication number
JP2007523056A5
JP2007523056A5 JP2006538192A JP2006538192A JP2007523056A5 JP 2007523056 A5 JP2007523056 A5 JP 2007523056A5 JP 2006538192 A JP2006538192 A JP 2006538192A JP 2006538192 A JP2006538192 A JP 2006538192A JP 2007523056 A5 JP2007523056 A5 JP 2007523056A5
Authority
JP
Japan
Prior art keywords
pyrophosphate
dialysate
compound
concentration
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006538192A
Other languages
English (en)
Japanese (ja)
Other versions
JP4838139B2 (ja
JP2007523056A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/035541 external-priority patent/WO2005044189A2/en
Publication of JP2007523056A publication Critical patent/JP2007523056A/ja
Publication of JP2007523056A5 publication Critical patent/JP2007523056A5/ja
Application granted granted Critical
Publication of JP4838139B2 publication Critical patent/JP4838139B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006538192A 2003-10-28 2004-10-27 透析液並びに透析液に関連した方法及びシステム Expired - Fee Related JP4838139B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51517403P 2003-10-28 2003-10-28
US60/515,174 2003-10-28
PCT/US2004/035541 WO2005044189A2 (en) 2003-10-28 2004-10-27 Dialysates and methods and systems related thereto

Publications (3)

Publication Number Publication Date
JP2007523056A JP2007523056A (ja) 2007-08-16
JP2007523056A5 true JP2007523056A5 (cg-RX-API-DMAC7.html) 2011-09-22
JP4838139B2 JP4838139B2 (ja) 2011-12-14

Family

ID=34572815

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006538192A Expired - Fee Related JP4838139B2 (ja) 2003-10-28 2004-10-27 透析液並びに透析液に関連した方法及びシステム

Country Status (9)

Country Link
US (1) US20070148258A1 (cg-RX-API-DMAC7.html)
EP (1) EP1682077A4 (cg-RX-API-DMAC7.html)
JP (1) JP4838139B2 (cg-RX-API-DMAC7.html)
KR (1) KR101249707B1 (cg-RX-API-DMAC7.html)
CN (2) CN103054901A (cg-RX-API-DMAC7.html)
AU (1) AU2004287440A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0416088A (cg-RX-API-DMAC7.html)
CA (1) CA2544235C (cg-RX-API-DMAC7.html)
WO (1) WO2005044189A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8187467B2 (en) * 2003-12-30 2012-05-29 Ajay Gupta Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion
EP2206504A4 (en) 2007-10-05 2014-02-12 Univ Chiba Nat Univ Corp STABLE IONIC BICARBONATE MEDICINES SOLUTION
US7658952B2 (en) * 2007-10-11 2010-02-09 Baxter International Inc. Dialysis solutions containing pyrophosphates
ES2332636B1 (es) * 2008-08-06 2011-02-10 Universitat De Les Illes Balears Composicion de liquido de dialisis.
JP5258448B2 (ja) * 2008-08-12 2013-08-07 扶桑薬品工業株式会社 透析用製剤
AU2015200995B2 (en) * 2010-04-23 2016-09-08 Vantive Health Gmbh Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
EP2560663B1 (en) * 2010-04-23 2016-06-22 Baxter International Inc. Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
CN102517635B (zh) * 2012-01-12 2014-12-24 中国科学院新疆理化技术研究所 化合物锂钾磷氧和锂钾磷氧晶体及其制备方法
EP2862583A1 (en) * 2013-10-17 2015-04-22 Gambro Lundia AB Perm selective membrane for treating vascular calcification in chronic hemodialysis patients
DE102015007842A1 (de) * 2015-06-18 2016-12-22 Fresenius Medical Care Deutschland Gmbh Dialyselösung
US20200009163A1 (en) * 2017-03-06 2020-01-09 University Of Houston System Polyphosphates as inhibitors of calcium crystallization
IT201700085412A1 (it) * 2017-07-26 2019-01-26 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
MX2021003653A (es) 2018-10-11 2021-06-23 Sanifit Therapeutics S A Inositol fosfatos para el tratamiento de calcificacion ectopica.
IT201900007329A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
CN118416279B (zh) * 2024-04-23 2025-09-02 大连医科大学附属第二医院 一种预防血管钙化的动静脉内瘘外用敷料及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9903442A3 (en) * 1996-02-08 2001-11-28 Warner Lambert Co Anticalculus dentifrice containing highly soluble pyrophosphate
AU736053B2 (en) * 1996-12-31 2001-07-26 Ajay Gupta Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients
US6689275B1 (en) * 1996-12-31 2004-02-10 Ajay Gupta Method and pharmaceutical composition for replacing iron losses in dialysis patients
US6779468B1 (en) * 1997-08-07 2004-08-24 Ajay Gupta Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients
EP1009452A4 (en) * 1997-08-07 2004-03-31 Ajay Gupta WATER-SOLUBLE VITAMINS AND DIALYSIS SOLUTION CONTAINING NUTRIENTS
JP2003519183A (ja) * 2000-01-04 2003-06-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 心臓および動脈の石灰化を抑制する低用量ビスホスホネートの使用
JP2002249433A (ja) * 2000-12-19 2002-09-06 Sumitomo Pharmaceut Co Ltd 血管石灰化抑制剤
US20040241249A1 (en) 2001-06-18 2004-12-02 Tina Sampalis Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases arthritis, skin cancer diabetes, premenstrual syndrome and transdermal transport
US6524788B1 (en) * 2001-11-02 2003-02-25 Thomas L. Cantor Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
US8187467B2 (en) * 2003-12-30 2012-05-29 Ajay Gupta Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion

Similar Documents

Publication Publication Date Title
JP4838139B2 (ja) 透析液並びに透析液に関連した方法及びシステム
Russell et al. 1, 25-dihydroxycholecalciferol and 1α-hydroxycholecalciferol in hypoparathyroidism
Perelló et al. Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis
JP5919597B2 (ja) デオキシコール酸およびその塩類の製剤
EA018245B1 (ru) Органические соединения трехвалентного железа фармацевтического качества, их применение и способы их получения
US20240197689A1 (en) Thiazolidinedione analogs for the treatment of nafld and metabolic diseases
CA3172535A1 (en) Cyclophilin inhibitors and uses thereof
EP0643969A2 (en) Pharmaceutical composition for renal disorder and a dialysis solution for extracorporeal hemodialysis
Hulter et al. Lipoid nephrosis appearing as acute oliguric renal failure
KR20210148078A (ko) 조직 관류 증가에 사용하기 위한 이노시톨 포스페이트 화합물
JP6219430B2 (ja) デオキシコール酸およびその塩類の製剤
JP6906807B2 (ja) 透析装置
WO1999040919A1 (en) Remedies for cardiac dilastolic disorders
TW200306811A (en) Medicinal compositions for inhibiting tryptase
WO2021197639A1 (en) Compositions comprising 15-hepe for treating or preventing hematologic disorders, and/or related diseases
MXPA06004730A (en) Dialysates and methods and systems related thereto
RU2358731C2 (ru) Cci-779 для лечения лимфомы из мантийных клеток
JPH0737388B2 (ja) 腎機能改善剤
WO2014159679A1 (en) Methods for using lubiprostone to absorb fluid from the subretinal space
Nieszporek et al. Does the kind of immunosuppressive therapy influence plasma renin activity, aldosterone and vasopressin in patients with a kidney transplant?
KR101758949B1 (ko) 활성 성분으로 l-카르니틴 또는 프로피오닐 l-카르니틴을 포함하는, 만성 정맥 기능부전의 예방 또는 치료용 복합 조성물
JP6356329B2 (ja) デオキシコール酸およびその塩類の製剤
JP6594486B2 (ja) デオキシコール酸およびその塩類の製剤
Lippens Methotrexate in the central nervous system prophylaxis of children with acute lymphoblastic leukemia
SU1588420A1 (ru) Способ профилактики отторжени аллотрансплантированной почки